News & Trends

How MB2 Dental Is Continuing Growth and Expansion: Q&A with Dr. Chris Villanueva

Chris Villanueva, DMD, is the founder and CEO of MB2 Dental, a dental partnership organization that added more than 120 practices to its network and reached the 500-practice milestone in 2022. He recently spoke with Becker’s about what sets MB2 Dental apart from other DSOs and DPOs, effective strategies for expanding and the company’s goals […]

How MB2 Dental Is Continuing Growth and Expansion: Q&A with Dr. Chris Villanueva Read More »

LHC to Delist from Nasdaq, Suggesting UnitedHealth Could Complete Acquisition Next Week

Wednesday is the last day that LHC Group will trade on the Nasdaq, suggesting UnitedHealth will complete its acquistion of the home health business prior to market open on Thursday. LHC’s stock will be halted aftermarket on Wednesday, according to a Nasdaq notice. As a result, the merger is tentatively scheduled to close the next

LHC to Delist from Nasdaq, Suggesting UnitedHealth Could Complete Acquisition Next Week Read More »

Teens’ Mental-Health Distress Could Be Worse than CDC Data Suggest

America’s teenagers are distressed coming out of the pandemic, reporting record levels of sadness and suicide risk, according to a report released this week by the Centers for Disease Control and Prevention. A closer look at how these numbers come together suggests that the data might be a little bit off: If anything, teens’ distress

Teens’ Mental-Health Distress Could Be Worse than CDC Data Suggest Read More »

SUNY Upstate, Crouse Hospitals Call off Merger Plan

SUNY Upstate University Hospital and Crouse Hospital have dropped their merger plan. The neighboring hospitals said in an announcement they have entered into an affiliation agreement, but will remain separate, independent entities. The hospitals have withdrawn applications they submitted to the state last year seeking approval to merge and have Upstate acquire Crouse. Read the

SUNY Upstate, Crouse Hospitals Call off Merger Plan Read More »

Cash-Strapped Doylestown Health Seeks to Sell off Major Retirement Home Division

Doylestown (Pa.) Health, which is undergoing a strategic review as it battles to become more financially secure, said it is aiming to sell off a key asset in its 517-unit Pine Run retirement community. The Pine Run asset, about an hour north of Philadelphia, is spread over two campuses and has been named among the

Cash-Strapped Doylestown Health Seeks to Sell off Major Retirement Home Division Read More »

Q&A: What the Rise of Private Equity Investments in Cardiology Means for Cardiologists and Their Patients

Private equity investors have started getting more involved in cardiology in recent years, echoing their rise in radiology, dermatology and other specialties. Consider, for instance, the sudden rise of multiple cardiology-focused physician practice management platforms in the United States. Why are private equity investors so interested in cardiology right now? What does this influx of

Q&A: What the Rise of Private Equity Investments in Cardiology Means for Cardiologists and Their Patients Read More »

How the Current Economic Downturn Impacts Healthcare Funding and Investor Strategy

While 2022 was a near-record year for private equity healthcare dealmaking and VC fundraising, the S&P 500 dropped nearly 20% last year. Funding for early-stage companies as well as digital health appears to have cooled. With economists predicting a recession, Fierce Healthcare spoke with investors and advisers about what capital markets currently look like for

How the Current Economic Downturn Impacts Healthcare Funding and Investor Strategy Read More »

Doing More with Moore: Biotech’s Tech Moment

Beyond tools for engineering biology, the biotech industry has also embraced the “mainstream” definition of tech: software. a16z partners Jorge Conde and Jay Rughani have long been big believers in what the intersection of AI and biological engineering means for the future of biotech: artificial intelligence will transform how we deconvolute disease biology and design

Doing More with Moore: Biotech’s Tech Moment Read More »

The Top 10 Medtech M&A Deals of 2022

According to stats from Evaluate Medtech, the total value of 2021’s 150 or so M&A deals topped at about $78 billion—a far cry from 2015, when nearly $130 billion changed hands, but still a high point in recent years. But in 2022, that exuberance waned. Following waves of COVID variants and other international challenges, the

The Top 10 Medtech M&A Deals of 2022 Read More »

Scroll to Top